Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia.

Leyh-Bannurah S, Prugger C, de Koning M, Goette H, Lellé R

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Human papillomavirus (HPV) infection is a prerequisite of cervical cancer, the leading cause of cancer mortality in Ethiopian women today. Data on Ethiopian cervical HPV prevalence and genotype distribution are rare, but essential as pre-vaccine baseline data to monitor changes after initiating HPV vaccination. The objectives of this study were to assess the cervical HPV prevalence, genotype distribution and associated correlates among female hospital outpatients in rural Ethiopia.We examined a consecutive sample of 537 women 15-64 years of age in rural Ethiopia between November and December 2006. Screening for low risk (LR) and high-risk (HR) cervical HPV infection was performed and HR positive samples were genotyped with a GP5+/6 + - and SPF10-primer based system.The age-standardized prevalence of HPV, HPV HR and HPV LR infection was 17.3% (95% CI 14.1-20.5), 15.8% (95% CI 12.7-18.9) and 3.9% (95% CI 2.3-5.6), respectively. Among HC2 HPV HR positive infections (n = 86), the most common genotype was HPV 16 (24.4%), followed by 52 (11.6%), 56 (10.5%) and 31 (10.5%). Non-married relationship and widowhood, increasing number of lifetime sexual partners, human immunodeficiency virus infection and non-traditional housing type, but not age, were significantly associated with HR HPV infection.These results on cervical HPV prevalence and genotype distribution may serve as baseline data in evaluating the impact of future HPV vaccination programmes in rural Ethiopia.

Details zur Publikation

FachzeitschriftInfectious Agents and Cancer
Jahrgang / Bandnr. / Volume9
Ausgabe / Heftnr. / Issue1
Seitenbereich33null
StatusVeröffentlicht
Veröffentlichungsjahr2014
Sprache, in der die Publikation verfasst istEnglisch
Link zum VolltextPM:25320636; ISI:000345800500001
StichwörterSub-Sahara Africa; RISK-FACTORS; COSTA-RICA; Ethiopia; CYTOLOGY; ASSAY; POPULATION; DNA probes; Papillomavirus infections; Epidemiology; HPV; INFECTION; Cervix uteri; SUB-SAHARAN AFRICA; DNA TEST; CANCER; Risk factors; risk factors; epidemiology; Cytology; DNA test; Sub-Sahara Africa; DNA probes; Papillomavirus infections; COSTA-RICA; CANCER; SUB-SAHARAN AFRICA; ETHIOPIA; POPULATION; INFECTION; ASSAY; RISK-FACTORS; CERVIX UTERI; HPV

Autor*innen der Universität Münster

Lellé, Ralph
Klinik für Frauenheilkunde und Geburtshilfe